Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer
Background Carcinoembryonic antigen (CEA) is the most widely used tumor marker in colon cancer; however, there has been controversy regarding the significance of preoperative serum CEA level as a prognostic factor for recurrence. In this study, we evaluated the optimal cutoff value and prognostic significance of preoperative serum CEA level in stage III colon cancer. Methods Based on a retrospective cohort of 965 patients with stage III colon cancer who underwent elective curative surgery and adjuvant chemotherapy with fluoropyrimidine and oxaliplatin (training set), we determined the optimal cutoff value of CEA for recurrence using the Contal and O’Quigley method. We assessed the prognostic value of this cutoff value in terms of disease-free survival (DFS) and overall survival (OS) in a prospective cohort of 268 patients with stage III colon cancer (validation set). A Cox proportional hazards model was used to explore the association of prognostic variables with DFS and OS. Results The statistically determined best cutoff value for CEA was 3 ng/mL in the training set. A high CEA level (≥3 ng/mL) was associated with inferior DFS (hazard ratio [HR] 4.609, 95 % confidence interval [CI] 2.028–10.474) and OS (HR 3.956, 95 % CI 1.127–13.882) in the validation set, while multivariate analysis showed that a high CEA level was an independent risk factor for DFS and OS in both study subsets. Conclusion Preoperative serum CEA level is an independent prognostic factor for DFS and OS in patients with stage III colon cancer after curative resection and adjuvant chemotherapy..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
Annals of surgical oncology - 24(2016), 1 vom: 03. Okt., Seite 227-235 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kim, Chang Gon [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
Electronic Supplementary Table |
|---|
| Anmerkungen: |
© Society of Surgical Oncology 2016 |
|---|
| doi: |
10.1245/s10434-016-5613-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2025825811 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2025825811 | ||
| 003 | DE-627 | ||
| 005 | 20230518082730.0 | ||
| 007 | tu | ||
| 008 | 200820s2016 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1245/s10434-016-5613-5 |2 doi | |
| 035 | |a (DE-627)OLC2025825811 | ||
| 035 | |a (DE-He213)s10434-016-5613-5-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a Kim, Chang Gon |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © Society of Surgical Oncology 2016 | ||
| 520 | |a Background Carcinoembryonic antigen (CEA) is the most widely used tumor marker in colon cancer; however, there has been controversy regarding the significance of preoperative serum CEA level as a prognostic factor for recurrence. In this study, we evaluated the optimal cutoff value and prognostic significance of preoperative serum CEA level in stage III colon cancer. Methods Based on a retrospective cohort of 965 patients with stage III colon cancer who underwent elective curative surgery and adjuvant chemotherapy with fluoropyrimidine and oxaliplatin (training set), we determined the optimal cutoff value of CEA for recurrence using the Contal and O’Quigley method. We assessed the prognostic value of this cutoff value in terms of disease-free survival (DFS) and overall survival (OS) in a prospective cohort of 268 patients with stage III colon cancer (validation set). A Cox proportional hazards model was used to explore the association of prognostic variables with DFS and OS. Results The statistically determined best cutoff value for CEA was 3 ng/mL in the training set. A high CEA level (≥3 ng/mL) was associated with inferior DFS (hazard ratio [HR] 4.609, 95 % confidence interval [CI] 2.028–10.474) and OS (HR 3.956, 95 % CI 1.127–13.882) in the validation set, while multivariate analysis showed that a high CEA level was an independent risk factor for DFS and OS in both study subsets. Conclusion Preoperative serum CEA level is an independent prognostic factor for DFS and OS in patients with stage III colon cancer after curative resection and adjuvant chemotherapy. | ||
| 650 | 4 | |a Overall Survival | |
| 650 | 4 | |a Oxaliplatin | |
| 650 | 4 | |a National Comprehensive Cancer Network | |
| 650 | 4 | |a National Comprehensive Cancer Network | |
| 650 | 4 | |a Electronic Supplementary Table | |
| 700 | 1 | |a Ahn, Joong Bae |4 aut | |
| 700 | 1 | |a Jung, Minkyu |4 aut | |
| 700 | 1 | |a Beom, Seung Hoon |4 aut | |
| 700 | 1 | |a Heo, Su Jin |4 aut | |
| 700 | 1 | |a Kim, Jee Hung |4 aut | |
| 700 | 1 | |a Kim, Young Jin |4 aut | |
| 700 | 1 | |a Kim, Nam Kyu |4 aut | |
| 700 | 1 | |a Min, Byung Soh |4 aut | |
| 700 | 1 | |a Koom, Woong Sub |4 aut | |
| 700 | 1 | |a Kim, Hoguen |4 aut | |
| 700 | 1 | |a Roh, Yun Ho |4 aut | |
| 700 | 1 | |a Ma, Bo Gyoung |4 aut | |
| 700 | 1 | |a Shin, Sang Joon |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of surgical oncology |d Springer International Publishing, 1994 |g 24(2016), 1 vom: 03. Okt., Seite 227-235 |w (DE-627)182355047 |w (DE-600)1200469-8 |w (DE-576)046647635 |x 1068-9265 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2016 |g number:1 |g day:03 |g month:10 |g pages:227-235 |
| 856 | 4 | 1 | |u https://doi.org/10.1245/s10434-016-5613-5 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_2018 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4112 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2016 |e 1 |b 03 |c 10 |h 227-235 | ||